124 related articles for article (PubMed ID: 34118788)
41. Synergistic active targeting of dually integrin αvβ3/CD44-targeted nanoparticles to B16F10 tumors located at different sites of mouse bodies.
Shi S; Zhou M; Li X; Hu M; Li C; Li M; Sheng F; Li Z; Wu G; Luo M; Cui H; Li Z; Fu R; Xiang M; Xu J; Zhang Q; Lu L
J Control Release; 2016 Aug; 235():1-13. PubMed ID: 27235150
[TBL] [Abstract][Full Text] [Related]
42. Structure-based design, synthesis and evaluation of novel anthra[1,2-d]imidazole-6,11-dione derivatives as telomerase inhibitors and potential for cancer polypharmacology.
Chen CL; Chang DM; Chen TC; Lee CC; Hsieh HH; Huang FC; Huang KF; Guh JH; Lin JJ; Huang HS
Eur J Med Chem; 2013 Feb; 60():29-41. PubMed ID: 23279865
[TBL] [Abstract][Full Text] [Related]
43. Norepinephrine Transporter as a Target for Imaging and Therapy.
Pandit-Taskar N; Modak S
J Nucl Med; 2017 Sep; 58(Suppl 2):39S-53S. PubMed ID: 28864611
[TBL] [Abstract][Full Text] [Related]
44. Tumor regression and curability of preclinical neuroblastoma models by PEGylated SN38 (EZN-2208), a novel topoisomerase I inhibitor.
Pastorino F; Loi M; Sapra P; Becherini P; Cilli M; Emionite L; Ribatti D; Greenberger LM; Horak ID; Ponzoni M
Clin Cancer Res; 2010 Oct; 16(19):4809-21. PubMed ID: 20702613
[TBL] [Abstract][Full Text] [Related]
45. Carbonic anhydrase IX correlates with survival and is a potential therapeutic target for neuroblastoma.
Ameis HM; Drenckhan A; Freytag M; Izbicki JR; Supuran CT; Reinshagen K; Holland-Cunz S; Gros SJ
J Enzyme Inhib Med Chem; 2016; 31(3):404-9. PubMed ID: 25884234
[TBL] [Abstract][Full Text] [Related]
46. Inhibition of the SK-N-MC human neuroblastoma cell line in vivo and in vitro by a novel nutrient mixture.
Waheed Roomi M; Kalinovsky T; Roomi NW; Niedzwiecki A; Rath M
Oncol Rep; 2013 May; 29(5):1714-20. PubMed ID: 23446555
[TBL] [Abstract][Full Text] [Related]
47. Design and synthesis of novel benzothiophene analogs as selective estrogen receptor covalent antagonists against breast cancer.
Bai C; Ren S; Wu S; Zhu M; Luo G; Xiang H
Eur J Med Chem; 2021 Oct; 221():113543. PubMed ID: 34022716
[TBL] [Abstract][Full Text] [Related]
48. Synthesis and cytotoxic evaluation of combretafurans, potential scaffolds for dual-action antitumoral agents.
Pirali T; Busacca S; Beltrami L; Imovilli D; Pagliai F; Miglio G; Massarotti A; Verotta L; Tron GC; Sorba G; Genazzani AA
J Med Chem; 2006 Aug; 49(17):5372-6. PubMed ID: 16913727
[TBL] [Abstract][Full Text] [Related]
49. Corticosterone up-regulates expression and function of norepinephrine transporter in SK-N-BE(2)C cells.
Sun Z; Fan Y; Zha Q; Zhu MY
J Neurochem; 2010 Apr; 113(1):105-16. PubMed ID: 20070865
[TBL] [Abstract][Full Text] [Related]
50. Discovery of
Sime W; Jemaà M; Abassi Y; Lasorsa VA; Bonne Køhler J; Hansson K; Bexell D; Michaelis M; Cinatl J; Strand D; Capasso M; Massoumi R
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911859
[TBL] [Abstract][Full Text] [Related]
51. Design and synthesis of new indole containing biaryl derivatives as potent antiproliferative agents.
Yuan S; Feng SQ; Li AQ; Zuo JH; Zhang DQ; Xing YJ; Xie Z; Yu B; Liu HM
Bioorg Chem; 2021 May; 110():104821. PubMed ID: 33812156
[TBL] [Abstract][Full Text] [Related]
52. Synthesis and characterization of fluorescent ligands for the norepinephrine transporter: potential neuroblastoma imaging agents.
Hadrich D; Berthold F; Steckhan E; Bönisch H
J Med Chem; 1999 Aug; 42(16):3101-8. PubMed ID: 10447954
[TBL] [Abstract][Full Text] [Related]
53. Biological evaluation of mitochondria targeting small molecules as potent anticancer drugs.
Luo S; Dang X; Wang J; Yuan C; Hu Y; Lei S; Zhang Y; Lu D; Jiang F; Fu L
Bioorg Chem; 2021 Sep; 114():105055. PubMed ID: 34144278
[TBL] [Abstract][Full Text] [Related]
54. An octopus-mimic PEGylated peptide as a specific integrin αvβ3 inhibitor for preventing tumor progression.
Shan X; Zhang L; Xu Y; Sun L; Guo L; Feng S; Ge H; Gu T; Ning X
Chem Commun (Camb); 2020 Feb; 56(14):2178-2181. PubMed ID: 31971174
[TBL] [Abstract][Full Text] [Related]
55. Design, synthesis and biological evaluation of novel 4-aminoquinazolines as dual target inhibitors of EGFR-PI3Kα.
Ding HW; Deng CL; Li DD; Liu DD; Chai SM; Wang W; Zhang Y; Chen K; Li X; Wang J; Song SJ; Song HR
Eur J Med Chem; 2018 Feb; 146():460-470. PubMed ID: 29407971
[TBL] [Abstract][Full Text] [Related]
56. Curcumin induces apoptosis in human neuroblastoma cells via inhibition of AKT and Foxo3a nuclear translocation.
Picone P; Nuzzo D; Caruana L; Messina E; Scafidi V; Di Carlo M
Free Radic Res; 2014 Dec; 48(12):1397-408. PubMed ID: 25179440
[TBL] [Abstract][Full Text] [Related]
57. Design, synthesis and biological evaluation of novel pyrenyl derivatives as anticancer agents.
Bandyopadhyay D; Sanchez JL; Guerrero AM; Chang FM; Granados JC; Short JD; Banik BK
Eur J Med Chem; 2015 Jan; 89():851-62. PubMed ID: 25462285
[TBL] [Abstract][Full Text] [Related]
58. Design, synthesis, and biological evaluation of combretabenzodiazepines: a novel class of anti-tubulin agents.
Galli U; Travelli C; Aprile S; Arrigoni E; Torretta S; Grosa G; Massarotti A; Sorba G; Canonico PL; Genazzani AA; Tron GC
J Med Chem; 2015 Feb; 58(3):1345-57. PubMed ID: 25584687
[TBL] [Abstract][Full Text] [Related]
59. Dual targeting of wild-type and mutant p53 by small molecule RITA results in the inhibition of N-Myc and key survival oncogenes and kills neuroblastoma cells in vivo and in vitro.
Burmakin M; Shi Y; Hedström E; Kogner P; Selivanova G
Clin Cancer Res; 2013 Sep; 19(18):5092-103. PubMed ID: 23864164
[TBL] [Abstract][Full Text] [Related]
60. Design, Synthesis, and Biological Evaluation of Novel Thiazolyl Substituted Bis-pyrazole Oxime Derivatives with Potent Antitumor Activities by Selectively Inducing Apoptosis and ROS in Cancer Cells.
Xiong B; Chen S; Zhu P; Huang M; Gao W; Zhu R; Qian J; Peng Y; Zhang Y; Dai H; Ling Y
Med Chem; 2019; 15(7):743-754. PubMed ID: 30147012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
